- Service Name
AI-Immunology™
- Industry
Biotechnology, Vaccine Development, AI Technology, Immunotherapy
- Main Value Proposition
The primary value offered is the ability to develop novel, personalized vaccines for cancer and infectious diseases quickly and effectively using AI technology.
- Description
AI-Immunology™ is an advanced AI platform developed by Evaxion Biotech for the rapid discovery, design, and development of personalized vaccines targeting cancer and infectious diseases. It utilizes unique AI building blocks to create tailored prediction models that address complex immune-related healthcare challenges.
- Key Features
Clinically validated AI platform for vaccine target discovery; Rapid identification of therapeutically relevant vaccine targets within 24 hours; Personalized and precision vaccine development; Multidisciplinary approach leveraging advanced AI and machine learning technologies
- Use Cases
The service is most valuable in scenarios involving the development of personalized vaccines for patients with cancer and infectious diseases, particularly in clinical settings where rapid and effective treatment options are needed.
- Competitive advantages
High success rate of 92% in vaccine manufacturing for enrolled patients; Ability to generate tailored AI prediction models addressing complex healthcare issues; Strong partnerships with big pharma, enhancing credibility and market reach
- Strengths
Evaxion's strengths lie in its innovative AI technology, clinically validated platform, and a robust pipeline of personalized vaccine candidates, supported by a multidisciplinary team and state-of-the-art facilities.
- Positioning
Evaxion positions itself as a pioneering TechBio company at the forefront of biotechnology, utilizing AI to revolutionize vaccine development.
- Audience
The target users include healthcare providers, pharmaceutical companies, and patients seeking innovative cancer and infectious disease treatments. The maximum value is derived by oncologists, immunologists, and researchers in the biotech field.
- Brand Positioning
The brand identity emphasizes innovation, precision, and a commitment to improving patient outcomes through advanced technology in vaccine development.
- CTA
Learn more
- Differentiation
Evaxion's AI-Immunology™ platform is unique in its combination of advanced AI technologies and a multidisciplinary approach, allowing for rapid and precise vaccine development tailored to individual patient needs.
- Tagline
Decoding the human immune system to develop novel vaccines for cancer and infectious diseases.
- Tags
AI technology
personalized vaccines
cancer treatment
infectious diseases
- Tone of Voice
Innovative, authoritative, optimistic
- Founded
2008-01-01
- Founders
Andreas Holm Mattsson
Niels Moeller